Vincent Angotti
Chief Executive Officer at TALPHERA, INC.
Net worth: 191 303 $ as of 2024-04-29
Vincent Angotti active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TALPHERA, INC. | Director/Board Member | 2017-03-05 | - |
| Chief Executive Officer | 2017-03-05 | - | |
| Director of Finance/CFO | 2017-06-01 | 2017-07-31 | |
| President | - | - |
Career history of Vincent Angotti
Former positions of Vincent Angotti
| Companies | Position | Start | End |
|---|---|---|---|
| XENOPORT, INC. | Director/Board Member | 2015-09-30 | 2016-06-30 |
| Chief Executive Officer | 2015-09-28 | 2016-06-30 | |
| Chief Operating Officer | 2012-06-04 | 2015-09-30 | |
| Corporate Officer/Principal | 2008-04-30 | 2012-06-04 | |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Sales & Marketing | 2000-12-31 | 2007-12-31 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 1990-12-31 | 2000-12-31 |
Training of Vincent Angotti
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Cornell University | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TALPHERA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Vincent Angotti
- Experience